Why GSK plc (GSK) Stock Is Up Today

By: Quiver PriceTracker

Posted: an hour ago / July 28, 2026 3:37 p.m. UTC

GSK

GSK plc (GSK) is up 4.8% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver is a strong second-quarter update that paired better underlying profit performance with a new plan to accelerate research and development. Investors also appear to be reacting positively to management’s cost-savings program, renewed pipeline momentum, and fresh oncology trial progress.

Details:

GSK said second-quarter sales rose to £8.4 billion, while core operating profit and core EPS increased, helped by strength in Specialty Medicines and Vaccines.

The company announced a three-year program targeting £1.9 billion in annual savings by 2029, with much of that capital intended to fund late-stage pipeline investment and support margins.

Management said it now expects more than 20 phase III trial starts in 2026, up from the prior expectation of 10, signaling a faster development pace for key assets.

Sentiment may have also improved because GSK highlighted recent oncology momentum, including an FDA approval for Jideytro, positive data for Jemperli in rectal cancer, and new late-stage progress for risvutatug rezetecan in osteosarcoma.

Sources:

GSK, MarketScreener, Investegate

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$GSK Hedge Fund Activity

We have seen 408 institutional investors add shares of $GSK stock to their portfolio, and 442 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

DODGE & COX removed 9,854,995 shares (-14.4%) from their portfolio in Q1 2026, for an estimated $543,897,174
JTC EMPLOYER SOLUTIONS TRUSTEE LTD removed 5,385,620 shares (-37.3%) from their portfolio in Q1 2026, for an estimated $297,232,367
MORGAN STANLEY added 5,201,988 shares (+89.2%) to their portfolio in Q1 2026, for an estimated $287,097,717
UBS GROUP AG removed 4,196,648 shares (-66.8%) from their portfolio in Q1 2026, for an estimated $231,613,003
ACADIAN ASSET MANAGEMENT LLC added 2,832,926 shares (+31.6%) to their portfolio in Q1 2026, for an estimated $156,349,185
FEDERATED HERMES, INC. removed 2,674,401 shares (-94.1%) from their portfolio in Q1 2026, for an estimated $147,600,191
HOLOCENE ADVISORS, LP removed 2,598,094 shares (-32.0%) from their portfolio in Q1 2026, for an estimated $143,388,807

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.